Inpatient smoking-cessation counseling and all-cause mortality in patients with acute myocardial infarction

被引:54
|
作者
Van Spall, Harriette G. C.
Chong, Alice
Tu, Jack V.
机构
[1] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada
[2] Univ Toronto, Div Cardiol, Toronto, ON, Canada
[3] Sunnybrook Hlth Sci Ctr, Div Gen Internal Med & Cardiol, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1016/j.ahj.2007.04.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Smoking cessation is associated with improved health outcomes, but the prevalence, predictors, and mortality benefit of inpatient smoking-cessation counseling after acute myocardial infarction (AMI) have not been described in detail. Methods The study was a retrospective, cohort analysis of a population-based clinical AMI database involving 9041 inpatients discharged from 83 hospital corporations in Ontario, Canada. The prevalence and predictors of inpatient smoking-cessation counseling were determined. Associations were drawn between counseling and all-cause 1-year mortality using multivariate Cox proportional hazards regression model and controlling for important validated predictors of post-Ml mortality. Results A majority of patients with AMI (67.4%) had a history of smoking and 39.0% were current smokers. Current smokers presented with AMI at a much younger average age than former- and never-smokers (mean [+/- SD] ages 59.0 +/- 12.5, 68.9 +/- 11.4, and 70.6 +/- 12.8 years, respectively). Only 52.16/. of current smokers were offered smokingcessation counseling. Multivariate predictors of counseling included a history of asthma (odds ratio [OR] 1.62, 95% CI 1. 15-2.3 1) and admission to a large hospital (OR 1.74, 95% CI 1.37-2.22). Factors associated with no counseling included increasing patient age (OR 0.69, 95% CI 0.65-0.74), a history of diabetes (OR 0.77, 95% CI 0.63-0.93), and admission under the care of a cardiologist (OR 0.67, 95% CI 0.52-0.85) or internist (OR 0.72, 95% CI 0.58-0.88). After adjustment for predictors of post-Ml mortality, counseled smokers had a lower risk of mortality (hazard ratio 0.63, 95% CI 0.44-0.90) than those not counseled. Conclusions Post-Ml inpatient smoking-cessation counseling is an underused intervention, but is independently associated with a significant mortality benefit. Given the minimal cost and potential benefit of inpatient counseling, we recommend that it receive greater emphasis as a routine part of post-Ml management.
引用
收藏
页码:213 / 220
页数:8
相关论文
共 50 条
  • [31] Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction
    Korhonen, Maarit J.
    Robinson, Jennifer G.
    Annis, Izabela E.
    Hickson, Ryan P.
    Bell, J. Simon
    Hartikainen, Juha
    Fang, Gang
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (13) : 1543 - 1554
  • [32] Postoperative Anemia is Associated with Nonfatal Myocardial Infarction and All-cause Mortality
    Kurt, Ruetzler
    Eva, Rivas
    Cohen, Barak
    Alparslan, Turan
    [J]. SWISS MEDICAL WEEKLY, 2020, : 9S - 10S
  • [33] A retrospective study on the relationship between fibrosis-4 index and all-cause mortality in patients with acute myocardial infarction
    Cao, Maolin
    Li, Tingming
    Li, Zhifeng
    Gong, Fang
    Chen, Zijun
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 24 (04)
  • [34] The neutrophil percentage-to-albumin ratio is associated with all-cause mortality in critically ill patients with acute myocardial infarction
    Lin, Ya
    Lin, Yanhan
    Yue, Juanqing
    Zou, Qianqian
    [J]. BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
  • [35] The neutrophil percentage-to-albumin ratio is associated with all-cause mortality in critically ill patients with acute myocardial infarction
    Ya Lin
    Yanhan Lin
    Juanqing Yue
    Qianqian Zou
    [J]. BMC Cardiovascular Disorders, 22
  • [36] Post-myocardial infarction smoking cessation counseling: Associations with immediate and late mortality in older Medicare patients
    Houston, TK
    Allison, JJ
    Person, S
    Kovac, S
    Williams, OD
    Kiefe, CI
    [J]. AMERICAN JOURNAL OF MEDICINE, 2005, 118 (03): : 269 - 275
  • [37] Growth differentiation factor-15 and all-cause mortality in patients with suspected myocardial infarction
    Walter, Joan
    Nestelberger, Thomas
    Boeddinghaus, Jasper
    Twerenbold, Raphael
    Croton, Lukas
    Badertscher, Patrick
    Wildi, Karin
    Wussler, Desiree
    de Lavallaz, Jeanne du Fay
    Mueller, Christian
    Gimenez, Maria Rubini
    Puelacher, Christian
    Kozhuharov, Nikola
    Morawiec, Beata
    Rentsch, Katharina
    Miro, Oscar
    Martin-Sanchez, F. Javier
    Muzyk, Piotr
    Geigy, Nicolas
    Keller, Dagmar I.
    Reichlin, Tobias
    Lohrmann, Jens
    Biskup, Ewalina
    Kloos, Wanda
    Lopez, Beatriz
    Fuenzalida Inostroza, Carolina
    Rodriguez Adrada, Esther
    Kawecki, Damian
    Muzyk, Piotr
    Nowalany-Kozielska, Ewa
    Parenica, Jiri
    Meissner, Kathrin
    Kulangara, Caroline
    Mahfouz, Riham
    Rentsch, Katharina
    von Eckardstein, Arnold
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 292 : 241 - 245
  • [38] Reduction of Myocardial Infarction and All-Cause Mortality Associated to Statins in Patients Without Obstructive CAD
    Ovrehus, Kristian A.
    Diederichsen, Axel
    Grove, Erik L.
    Steffensen, Flemming H.
    Mortensen, Martin B.
    Jensen, Jesper M.
    Mickley, Hans
    Nielsen, Lene H.
    Busk, Martin
    Sand, Niels Peter R.
    Lambrechtsen, Jess
    Riis, Anders H.
    Andersen, Ina Trolle
    Botker, Hans E.
    Norgaard, Bjarne L.
    [J]. JACC-CARDIOVASCULAR IMAGING, 2021, 14 (12) : 2400 - 2410
  • [39] Association of SGLT2 inhibitor dapagliflozin with risks of acute kidney injury and all-cause mortality in acute myocardial infarction patients
    Cai, Dabei
    Chen, Qianwen
    Mao, Lipeng
    Xiao, Tingting
    Wang, Yu
    Gu, Qingqing
    Wang, Qingjie
    Ji, Yuan
    Sun, Ling
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (04) : 613 - 620
  • [40] Association of SGLT2 inhibitor dapagliflozin with risks of acute kidney injury and all-cause mortality in acute myocardial infarction patients
    Dabei Cai
    Qianwen Chen
    Lipeng Mao
    Tingting Xiao
    Yu Wang
    Qingqing Gu
    Qingjie Wang
    Yuan Ji
    Ling Sun
    [J]. European Journal of Clinical Pharmacology, 2024, 80 : 613 - 620